Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2021-04-20 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
股东大会议事规则
Governance Information Classification · 100% confidence The document is titled as the "Rules of Procedure for the Shareholders' General Meeting" of Guangzhou Yangpu Medical Technology Co., Ltd. It extensively details the procedures, powers, rights, and responsibilities related to the shareholders' meetings, including the convening, proposal submission, voting, resolutions, and record-keeping. It does not contain financial statements, audit opinions, or earnings data. It is a governance document outlining internal rules and processes for shareholder meetings. Therefore, it fits the category of Governance Information (CGR). The document length is substantial and contains detailed governance rules, not just an announcement or summary, so it is not an RPA or RNS.
2021-04-20 Chinese
董事会秘书工作制度
Governance Information Classification · 95% confidence The document is titled '董事会秘书工作制度' which translates to 'Board Secretary Work System'. It outlines the duties, qualifications, appointment, and dismissal procedures of the company's board secretary. It references relevant laws and regulations such as the Company Law, Securities Law, and Shenzhen Stock Exchange rules. The content is focused on governance practices and internal rules related to the board secretary role rather than financial results, audit, or shareholder meeting materials. It does not contain financial data, earnings, or voting results. It is a governance-related document detailing internal company rules and responsibilities of a key management role. Therefore, it fits best under Governance Information (CGR). The document length is 4036 characters, which is sufficient for a detailed governance report rather than a brief announcement or certification.
2021-04-20 Chinese
2020年度董事会工作报告
Management Reports Classification · 95% confidence The document is titled '2020 年度董事会工作报告' which translates to '2020 Annual Board of Directors Work Report'. It details the board's activities, company performance, governance, and future plans for the year 2020. The content includes comprehensive discussion of company operations, financial performance, governance, and board meetings throughout the year. It is a detailed report from the board of directors about their work and the company's status over the fiscal year. This matches the description of a Management Reports (MDA) filing, which provides management's detailed explanation of financial results, business trends, and outlook. The document is not a full Annual Report (10-K) as it lacks full financial statements and audit opinions, nor is it a simple announcement or certification. It is also not a Board/Management Information (MANG) announcement of changes in board members, but a substantive report on board activities and company management. Therefore, the best classification is Management Reports (MDA).
2021-04-20 Chinese
2021年第一季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled "广州阳普医疗科技股份有限公司 2021 年第一季度报告全文" which translates to "Guangzhou Yangpu Medical Technology Co., Ltd. 2021 First Quarter Report Full Text." It contains detailed financial data including consolidated balance sheets, profit and loss statements, cash flow statements, and extensive management discussion on business performance, risks, and outlook for the first quarter of 2021. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement. The content includes actual financial statements and substantive financial data for a period shorter than a full fiscal year (quarterly). Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2021
2021-04-20 Chinese
内部控制制度
Governance Information Classification · 95% confidence The document is titled as an internal control system of Guangzhou Yangpu Medical Technology Co., Ltd. It extensively details the company's internal control policies, including risk management, related party transactions, guarantees, entrusted financial management, fundraising, and external commitments. The content is focused on internal governance, compliance with laws and stock exchange rules, and operational controls rather than financial results or audit opinions. There is no indication that this is an annual report, audit report, earnings release, or any other financial statement. It is a detailed governance and internal control document, which aligns with Governance Information (CGR) as it covers internal rules, board structure, and governance practices. The document length is substantial (15,000 characters), indicating it is the full report, not just an announcement. Therefore, the appropriate classification is Governance Information (CGR).
2021-04-20 Chinese
2020年度监事会工作报告
Management Reports Classification · 95% confidence The document is titled '2020 年度监事会工作报告' which translates to '2020 Supervisory Board Work Report'. It details the supervisory board's activities, meetings, and opinions on the company's 2020 financial and operational matters. It includes references to the 2020 annual report, quarterly reports, and audit opinions, but it is itself a report from the supervisory board rather than the full annual report or audit report. The document length is 3259 characters, which is relatively short but contains substantive content about the supervisory board's oversight and opinions on the company's governance and financials for the year 2020. This type of document is best classified under Management Reports (MDA), as it provides management's detailed explanation and oversight commentary on financial results, business trends, and outlook, rather than being the full Annual Report (10-K) or Audit Report (AR).
2021-04-20 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.